chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 82-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration, administered in the right arm on 17Feb2021 06:30 (at the age of 82-years-old), as first dose, single dose for COVID-19 immunisation. Medical history included lipoma. Concomitant medications included hydrochlorothiazide (HTZ); levothyroxine, both taken for an unspecified indication, start and stop dates were not reported. The patient previously took ciprofloxacin (CIPRO), denusomab (PROLIA), and risedronate and experienced drug hypersensitivity. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. After the first shot, the patient experienced vertigo and dizziness on an unspecified date in Feb2021 06:00. Patient reported events lasted 3 weeks. It was unknown if patient received treatment as a result of events. Patient did not seek consult to physician or urgent care. The outcome of events was recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness in the face; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and Expiration Date: not reported), via an unspecified route of administration, administered in right arm on 13Mar2021 at 00:15 (reported as 12:15 AM) (at the age of 52 years old) as first dose, single for COVID-19 immunisation in a Public Health Clinic/Veterans Administration facility. Patient has known allergies with Penicillin from an unknown date. The patient was not pregnant at the time of vaccination and prior to vaccine the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines in  4 weeks prior to the COVID vaccine and has no list of any other medications received within 2 weeks of vaccination. The patient experienced numbness in the face on 13Mar2021 at 12:45 (reported as 12:45 PM). No treatment was received for the adverse event. Since vaccination, the patient has not been tested for COVID-19. Outcome of the event was recovering.    No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Vaccination site pain
Clinical narrative: This is a spontaneous report from a non-contactable consumer (patient). A 29-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EP6955; Expiration date was not reported), via unspecified route of administration on an unspecified date in Mar 2021 (reported as 10:00 AM) (at the age of 29-years-old) as first dose, single dose for COVID-19 immunization. Medical history included COVID-19 (COVID prior vaccination) from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient was not tested for COVID post vaccination. The patient has no known allergies. On an unspecified date in Mar 2021 (reported as 04:00 PM), the patient experienced heavy fatigue, weakness and pain at injection site. No treatment was taken for the events. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19, UNK
Symptoms: Back pain
Clinical narrative: for his back pain; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team and from a Pfizer sponsored program, COVAX US Support. A 68-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Mar2021 (Batch/Lot number was not reported) as first dose, single dose for COVID-19 immunisation and ibuprofen, route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication. The patient's medical history and concomitant medications were not reported. Patient was asking if he can take aspirin or Tylenol or ibuprofen or diclofenac? On 13Mar2021, the patient claimed that he has not taken any medication yet and asked if he can take Tylenol or Aspirin for his back pain. The action taken in response to the event for ibuprofen was unknown. The outcome of the event was unknown.  No follow-up attempts are needed. No further information expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia, Vaccination site pain
Clinical narrative: Chills; low grade fever (100.2); some soreness at injection site; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EN6207,  Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 11Mar2021 14:30 (at the age of 67-years-old) as 1st dose, single dose for COVID-19 immunisation. Medical history included cardiovascular disease, GERD and lung blood clots all from unknown date. Concomitant medications included rosuvastatin, rivaroxaban (XARELTO), metoprolol, losartan and Famat all taken for an unspecified indication, start and stop date were not reported. The patient has no known allergies. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination, the patient has been diagnosed with COVID-19. On 12Mar2021 09:00, the patient experienced chills, low grade fever (100.2) and some soreness at injection site. Therapeutic measures were taken as a result of the events included TYLENOL. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was recovered on an unspecified date in Mar2021.    No follow-up attempts are possible. No further information expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Mild headache; tiredness was mild also; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration, administered in the left arm on 10Mar2021 13:00 (at the age of 64-years-old), as first dose, single dose for COVID-19 immunisation. Medical history included Diabetic and high BP. The patient received unspecified medication/s within 2 weeks of vaccination. The patient previously took naproxen (reported as naproxyn) and experienced drug hypersensitivity. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced mild headache and tiredness was mild also on 11Mar2021 08:00. No treatment was received as a result of the events. Patient did not seek consult to physician or urgent care. The outcome of events was recovered on an unspecified date in Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Heart rate, Heart rate increased
Clinical narrative: Pain in the chest after getting it heart beating fast; Pain in the chest after getting it heart beating fast; This is a spontaneous report from a contactable consumer (patient). A 21-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EN6208, Expiration Date: not reported), via an unspecified route of administration, administered in left arm on 13Mar2021 at 12:00 (at the age of 21 years old) as first dose, single for COVID-19 immunisation. The facility where the vaccine was administered was reported to be "other". The patient's  medical history and concomitant medications were not reported. The patient experienced pain in the chest after getting it heart beating fast on an unspecified date. Outcome of all events was unknown.  No follow-up attempts are possible.  No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal distension, Dizziness, Nausea
Clinical narrative: Stomach bloating; Nausea; lightheaded; This is a spontaneous report from a contactable consumer (patient). A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number and expiration date were not reported), via unspecified route of administration in the left arm on 08Mar2021 09:45 AM (at the age of 52-years-old) as first dose, single dose for COVID-19 immunisation at a Pharmacy or Drug Store. The patient has no relevant medical history. The patient has no concomitant medications. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. The patient has no known allergies. On 08Mar2021, the patient experienced stomach bloating, nausea and lightheaded. No treatment was taken for the events. The outcome of the events was recovered on an unspecified date in Mar2021.  No follow up attempts are possible; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Sore injection site; fatigue; This is a spontaneous report from a contactable consumer (patient). A 52-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number and Expiration date were not reported), via an unspecified route of administration (administered on the right arm) on 25Feb2021 15:00 (at the age of 52-years-old) as 1st dose, single dose for COVID-19 immunisation. Medical history included COVID-19 from an unknown date.    The patient's concomitant medications were not reported. The patient has no known allergies. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. The patient has no other medications in two weeks. On 25Feb2021, the patient experienced sore injection site and fatigue. No treatment was received for the events. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9266, expiration date not reported), via an unspecified route of administration, administered in the left arm on 04Mar2021 01:00 (at the age of 74-years-old), as first dose, single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD). Patient has no known allergies. The patient's concomitant medications were not reported. The patient previously received flu vaccine for Immunisation and experienced diarrhea (reported as If I take the senior flu shot diarrhea lasts 6 months & regular dose a couple of weeks). The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced diarrhea after eating on 05Mar2021. No treatment was received as a result of the events. Patient did not seek consult to physician or urgent care. The outcome of event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, SARS-CoV-2 test
Clinical narrative: Weekness; This is a spontaneous report from a contactable consumer (patient). An 82-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number and expiration date were not reported), via unspecified route of administration in the right arm on 02Mar2021 12:00 AM (at the age of 82-years-old) as second dose, single dose for COVID-19 immunisation at a hospital. Patient's medical history was not reported. Concomitant medications included antihistamines taken for an unspecified indication, start and stop dates were not reported. The patient was not pregnant at the time of vaccination. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination. On 02Mar2021 12:00 AM, the patient experienced weekness. No treatment was taken for the events. The patient underwent lab test and procedure which included SARS-CoV-2 test (nasal swab, PCR test): negative on 03Mar2021. The outcome of the events was not recovered.  No follow up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Sick for two days; This is a spontaneous report from a contactable consumer. A 61-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 vaccine; batch/lot number was not reported), via an unspecified route of administration on 09Mar2021 as 2nd dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient had the second shot and was sick for two days on an unspecified date. The outcome of the event was recovered.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Rash maculo-papular, Rash pruritic, Scab, Skin burning sensation
Clinical narrative: itchy rash on left forearm (given in same arm); itchy rash on left forearm (given in same arm); Lesions were red raised spots with vesicle in center that then began crusting. Very itchy, sometimes burning; Lesions were red raised spots with vesicle in center that then began crusting. Very itchy, sometimes burning; Lesions were red raised spots with vesicle in center that then began crusting. Very itchy, sometimes burning; Lesions were red raised spots with vesicle in center that then began crusting. Very itchy, sometimes burning; Lesions were red raised spots with vesicle in center that then began crusting. Very itchy, sometimes burning; This is a spontaneous report from a contactable healthcare professional (patient). A 38-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number and Expiration date were not reported), via an unspecified route of administration (administered on the left arm) on 04Mar2021 11:30 (at the age of 38-years-old) as 2nd dose, single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications included sertraline hydrochloride (ZOLOFT), probiotics and ascorbic acid, calcium pantothenate, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol palmitate, riboflavin, thiamine mononitrate (PRENATAL VITAMINS) all taken for an unspecified indication, start and stop date were not reported. The patient has no known allergies. Prior to vaccination, the patient has not been diagnosed with COVID-19. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. The patient was previously vaccinated with the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number and Expiration date were not reported), via an unspecified route of administration (administered on the left arm) on 09Feb2021 09:30 (at the age of 38-years-old) for COVID-19 immunisation. On 04Mar2021 13:00, the patient experienced itchy rash on left forearm (given in same arm) and lesions were red raised spots with vesicle in center that then began crusting. very itchy, sometimes burning. It was reported that itchy rash on left forearm that started about 1 hour after vaccine (given in same arm). Lesions continued to worsen and more developed over next week. Lesions were red raised spots with vesicle in center that then began crusting. Very itchy, sometimes burning. Most lesions on forearm but did develop a few solitary lesions on hip, leg, and back of neck. Therapeutic measures were taken as a result of the events included antibiotics and steroid cream. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Skin lesion, Vaccination site rash
Clinical narrative: itchy rash on left forearm (given in same arm); itchy rash on left forearm (given in same arm); Lesions were red raised spots with vesicle in center that then began crusting. Very itchy, sometimes burning; Lesions were red raised spots with vesicle in center that then began crusting. Very itchy, sometimes burning; Lesions were red raised spots with vesicle in center that then began crusting. Very itchy, sometimes burning; Lesions were red raised spots with vesicle in center that then began crusting. Very itchy, sometimes burning; Lesions were red raised spots with vesicle in center that then began crusting. Very itchy, sometimes burning; This is a spontaneous report from a contactable healthcare professional (patient). A 38-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number and Expiration date were not reported), via an unspecified route of administration (administered on the left arm) on 04Mar2021 11:30 (at the age of 38-years-old) as 2nd dose, single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications included sertraline hydrochloride (ZOLOFT), probiotics and ascorbic acid, calcium pantothenate, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol palmitate, riboflavin, thiamine mononitrate (PRENATAL VITAMINS) all taken for an unspecified indication, start and stop date were not reported. The patient has no known allergies. Prior to vaccination, the patient has not been diagnosed with COVID-19. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. The patient was previously vaccinated with the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number and Expiration date were not reported), via an unspecified route of administration (administered on the left arm) on 09Feb2021 09:30 (at the age of 38-years-old) for COVID-19 immunisation. On 04Mar2021 13:00, the patient experienced itchy rash on left forearm (given in same arm) and lesions were red raised spots with vesicle in center that then began crusting. very itchy, sometimes burning. It was reported that itchy rash on left forearm that started about 1 hour after vaccine (given in same arm). Lesions continued to worsen and more developed over next week. Lesions were red raised spots with vesicle in center that then began crusting. Very itchy, sometimes burning. Most lesions on forearm but did develop a few solitary lesions on hip, leg, and back of neck. Therapeutic measures were taken as a result of the events included antibiotics and steroid cream. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Musculoskeletal stiffness, Pyrexia
Clinical narrative: mild fever; stiffness (back as well as arms); 2.5 days of fatique; This is a spontaneous report from a contactable consumer or other non hcp (patient himself). A 33-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (at the age of 33 years old; batch/lot number and expiration date not reported) as first dose, single dose and via an unspecified route of administration, administered in the left arm on an unspecified date (at the age of 33 years old; batch/lot number and expiration date not reported) as second dose, single dose, both for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient experienced 2.5 days of fatique, mild fever, and stiffness (back as well as arms) on an unspecified date. No treatment was received as a result of the events. Patient did not seek consult to physician or urgent care. The outcome of event was recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Nausea continues since the day after (Now a week); Occasional stabbing pain on top of head; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EN699, Expiration Date: not reported), via an unspecified route of administration on an unspecified date in Mar2021 at 15:30 (reported as 03:30 PM) (at the age of 69 years old) as unknown, single for COVID-19 immunisation in a Pharmacy or Drug Store. Medical history included Small intestinal bacterial overgrowth (SIBO) and rash from some antibiotics from an unknown date. Prior to vaccine the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines in 4 weeks. Concomitant medication included paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. On 03Mar2021, the patient experienced nausea continues since the day after (Now a week, as reported) and occasional stabbing pain on top of head. No treatment was received for the adverse event. Since vaccination, the patient has not been tested for COVID-19. Outcome of all events was not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site erythema, Vaccination site induration
Clinical narrative: Generalized rash; Red, hard, circle approximately 3 inches in diameter at injection site; Red, hard, circle approximately 3 inches in diameter at injection site; This is a spontaneous report from a contactable consumer (patient). An 85-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN6201; Expiration date were not reported), via unspecified route of administration in the left arm on 26Feb2021 as first dose, single dose for COVID-19 immunisation at a Pharmacy or Drug Store. Medical history included glaucoma, hypertension (HTN), mild COPD and Penicillin (PCN) allergy; all from an unknown date and unknown if ongoing. Concomitant medications included aliskiren fumarate (TEKTURNA) taken for an unspecified indication, start and stop dates were not reported. The patient previously took vancomycin and experienced drug allergy. The patient was not pregnant at the time of vaccination. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. On an unspecified date (reported as one week after the injection), the patient experienced generalized rash. On 12Mar2021 07:00 AM (reported as two weeks after injection), the patient also experienced red, hard, circle approximately 3 inches in diameter at injection site occurred on left arm. No treatment was taken for the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rash papular, Rash pruritic, Vaccination site rash
Clinical narrative: raised red and itchy bumps on back of left arm 5 days received the 1st covid vaccine in the same arm / 2 inch by 5 inch patch above elbow in upper left arm; raised red and itchy bumps on back of left arm 5 days received the 1st covid vaccine in the same arm; raised red and itchy bumps on back of left arm 5 days received the 1st covid vaccine in the same arm; This is a spontaneous report from a contactable nurse (patient). A 65-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number and Expiration date were not reported), via an unspecified route of administration (administered on the left arm) on 04Mar2021 10:00 (at the age of 65-years-old) as 1st dose, single dose for COVID-19 immunisation. Medical history included diabetes, high blood pressure, and penicillin allergy all from an unknown date. The patient's concomitant medications were not reported. Prior to vaccination, the patient has not been diagnosed with COVID-19. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. The patient has no other medications in 2 weeks. On 09Mar2021 18:00, the patient experienced raised red and itchy bumps on back of left arm 5 days received the 1st covid vaccine in the same arm / 2 inch by 5 inch patch above elbow in upper left arm and raised red and itchy bumps on back of left arm 5 days received the 1st covid vaccine in the same arm. No treatment was received for the events. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Malaise, Pain
Clinical narrative: Weak feeling; felt sick; body was sore; This is a spontaneous report from a non-contactable consumer (patient reporting for himself). A 69-year-old male patient BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration, on 12Mar2021 (at the age of 69 years old) as 2nd dose, single dose, for COVID-19 immunisation. The patient's medical history included stroke from May2019 to an unknown date. The patient has no known allergies. The patient had no COVID prior vaccination and was not tested post-vaccination. The patient's concomitant medications were not reported. Historical vaccine included 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: unknown), on 16Feb2021, for COVID-19 immunisation. On 13Mar2021 at 02:30 A.M, it was reported that the patient felt sick. His body was sore and felt as if he got hit by a truck, and he has a weak feeling. The outcome of the events was recovering.  No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Throat irritation
Clinical narrative: She has an itchy throat and soreness to her arm; She has an itchy throat and soreness to her arm; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 12Mar2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. The patient medical history include exposure to COVID-19 (her son, who she is around a lot and gives her a kiss every morning tested positive for COVID) and concomitant medications were not reported. Patient reported that she received her first Covid vaccine dose yesterday (12Mar2021) and her son, who she was around a lot and gives her a kiss every morning tested positive for COVID. She reported that she has an itchy throat and soreness to her arm but no other symptoms at this time. She asked if she should go get tested for covid. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Feeling abnormal, Hypersomnia
Clinical narrative: doesn't feel like herself; tired; slept most of the morning; chills and put on a sweater; felt unwell all day; fever of 100 degrees; This is a spontaneous report from a contactable consumer (patient). An 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 12Mar2021 14:00 (Lot Number: EN6206; Expiration Date: 30Jun2021) as 2nd dose, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Feb2021 (Lot #EN6201, Exp;. 30Jun2021) for COVID-19 immunization. On 13Mar2021, the patient experienced the following side effects: didn't feel like herself, tired, slept most of the morning, chills and put on a sweater, felt unwell all day and fever of 100 degrees. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pyrexia
Clinical narrative: doesn't feel like herself; tired; slept most of the morning; chills and put on a sweater; felt unwell all day; fever of 100 degrees; This is a spontaneous report from a contactable consumer (patient). An 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 12Mar2021 14:00 (Lot Number: EN6206; Expiration Date: 30Jun2021) as 2nd dose, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Feb2021 (Lot #EN6201, Exp;. 30Jun2021) for COVID-19 immunization. On 13Mar2021, the patient experienced the following side effects: didn't feel like herself, tired, slept most of the morning, chills and put on a sweater, felt unwell all day and fever of 100 degrees. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site lymphadenopathy, Vaccination site rash
Clinical narrative: itchy sensation; Rash at injection site/Rectangular shape rash under injection site; Swollen lymph node on same side as injection; This is a spontaneous report from a contactable consumer (patient). A 33-year-old non-pregnant female patient received bnt162b2 (Lot Number: EN6206), via an unspecified route of administration, administered in left arm on 10Mar2021 10:00 AM (at the age of 33 years old) as single dose for covid-19 immunization. Medical history included juvenile asthma, patient had allergy coconut. Concomitant medication in two weeks included ethinylestradiol/ levonorgestrel (JOLESSA, contraceptive pills). The patient had not COVID prior vaccination and did not have COVID tested post vaccination. The patient had other vaccine in four weeks, included unspecified Pfizer vaccine (Lot number: EN9809) on 17Feb2021. The patient experienced rash at injection site day after 11Mar2021 (12Mar2021). Swollen lymph node on same side as injection on 11Mar2021 at 07:00. Rectangular shape rash under injection site and itchy sensation on 13Mar2021 upon waking. Second rash is approximately 1" tall by 2.5" wide. No treatment for events. The outcome of events was not recovered.  No follow up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 37-year-old non-pregnant female patient received bnt162b2 (Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in right arm on 11Mar2021 at 12:00 PM (at the age of 37 years old) as single dose for covid-19 immunization. Medical history included chronic allergies. The patient had not COVID prior vaccination and did not have COVID tested post vaccination. Concomitant medications in two weeks included omeprazole magnesium (PRILOSEC), amfetamine aspartate/ amfetamine sulfate/ dexamfetamine saccharate/ dexamfetamine sulfate (ADDERALL). The patient received other vaccine on same date 11Mar2021. The patient had no other vaccine in four weeks. The patient experienced delayed skin rash on arm on 14Mar2021 01:00 AM. No treatment for event. The outcome of event was nor recovered.   No follow-up attempts are possible. No further information is expected. The information about lot number and expiration date cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness at site of vaccine when lifting arm and some movements, tender to touch-mild; This is a spontaneous report from a contactable healthcare professional (patient). A 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot Number: EP6955) via an unspecified route of administration administered in left arm on 13Mar2021 at 13:45 (at 60 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. Medical history included allergic rhinitis and known allergies: peanuts and penicillin. The patient previously took vancomycin and experienced allergies. Concomitant medications included fluoxetine, fluticasone propionate (FLONASE), calcium, vitamin B complex (B COMPLEX), and colecalciferol (VIT D3); all from unspecified date for unspecified indication. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. The patient experienced only soreness at site of vaccine when lifting arm and some movements, tender to touch-mild; non-serious on 13Mar2021. No treatment received for the events. Outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Head discomfort
Clinical narrative: felt a chemical rush to my head; dizzy; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 57-year-old non-pregnant female patient received bnt162b2 (Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in left arm on 13Mar2021 (at the age of 65 years old) as single dose for covid-19 immunization. Medical history included allergy to sulfur based drugs. The concomitant medications in two weeks included vitamins. The patient had no other vaccine in four weeks. The patient felt a chemical rush to my head and felt a little dizzy on 13Mar2021. The patient had not COVID prior vaccination and did not have COVID tested post vaccination. No treatment for events. The outcome of events was recovered.   No follow-up attempts are possible. No further information is expected. The information about lot number and expiration date cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site pain
Clinical narrative: lymph node swelling left armpit, lymph node swelling left neck/lower jaw area; pain at injection site; This is a spontaneous report from a contactable consumer (patient). A 62-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot Number: En6205) via an unspecified route of administration administered in left arm on 04Mar2021 at 14:15 as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. Medical history included high blood pressure, high cholesterol, heart disease, and asthma; all from unspecified date. The patient had no known allergies. The patient's concomitant medications were not reported. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. The patient experienced pain at injection site on 05Mar2021 (next day), lymph node swelling left armpit which started 08Mar2021, and lymph node swelling left neck/lower jaw area which started on 13Mar2021, all non-serious. Adverse event treatment included acetaminophen and ice. Outcome of the events was recovering.  No follow up attempts are possible. No further information is expected.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: very mild soreness at the injection site when touched; This is a spontaneous report from a contactable consumer (patient) reported for himself. This consumer reported similar events for two patients (husband and wife). A 77-year-old male patient received bnt162b2 (Lot Number: En6204; Expiration Date: Jun2021), dose 1 via an unspecified route of administration, administered in left arm on 11Mar2021 (at the age of 77 years old) as single dose for covid-19 immunization. The patient previously received bnt162b2 (Lot Number: En6201; Expiration Date: Jun2021), dose 1 via an unspecified route of administration, administered in left arm on 18Feb2021 at 11:00 AM (at the age of 77 years old) as single dose for covid-19 immunization. Medical history included diabetes, enlarged prostate, and the patient had known allergies. The patient had no other vaccine in four weeks. Concomitant medications in two weeks included metformin, glimepiride, tamsulosin, latanoprost. Neither his wife nor he had any adverse event other than very mild soreness at the injection site when touched on 11Mar2021 11:00 AM. How can they be sure that the vaccine was viable or if it was not temperature controlled not effective. He was concerned. The patient had not COVID prior vaccination and did not have COVID tested post vaccination. No treatment for the event. The outcome of event was unknown.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021290939 same reporter/drug/AE different patient
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: minor pain at injection site; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot Number: EL3247) via an unspecified route of administration administered in left arm on 12Mar2021 (at 52 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. Medical history included migraines and latex and penicillin allergies; all from unspecified date. The patient previously took neomycin and experienced allergies. Concomitant medications included gabapentin and omeprazole both from unspecified date for unspecified indication. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. The patient experienced minor pain at injection site, which was non serious on 12Mar2021. No treatment received for the event. Outcome of the event was recovered on unspecified date in Mar2021.    No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain, Therapeutic response unexpected, Vaccination site pain
Clinical narrative: pain in left knee was completely gone/completely pain free when going up and down the stairs/not taking any pain medication, the only difference was getting the second dose of the vaccine; Soreness of left arm in the area of the injection; Headache; Body aches; This is a spontaneous report from a contactable consumer (patient). A 46-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot Number: EL3247) via an unspecified route of administration administered in left arm on 12Mar2021 at 12:30 (at 46 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. Medical history included cardiomyopathy and pain in left knee both from unspecified date. The patient had no known allergies. Concomitant medications included metoprolol 150mg and candesartan 16mg both from unspecified date for unspecified indication. The patient previously took the first dose of BNT162B2 (Lot Number: EL3247) via an unspecified route of administration administered in left arm on 19Feb2021 at 12:30 (at 45 years old) as single dose for COVID-19 immunization. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. The patient experienced soreness of left arm in the area of the injection, headache, and body aches; all non-serious on 13Mar2021. No treatment received for the events. The patient also added that for many years he had pain in left knee that would typically be felt when going up or down the stairs. However, over the past couple of days from the time of reporting on 14Mar2021, the patient noticed that the pain in left knee is completely gone. The patient was completely pain free when going up and down the stairs. The patient was not taking any pain medication, the only difference was getting my second dose of the vaccine on 12Mar2021. Outcome of the events was recovered on unspecified date in Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pyrexia, Vaccination site erythema
Clinical narrative: Headache; muscle pain; fever; exhaustion; injection site swollen, red and itchy; injection site swollen, red and itchy; injection site swollen, red and itchy; This is a spontaneous report from a contactable consumer (patient). A 48-year-old non-pregnant female patient received bnt162b2 (Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in left arm on 11Mar2021 08:15 AM (at the age of 48 years old) as single dose for covid-19 immunization. Medical history included asthma, high blood pressure, lymphedema, postoperative hypothyroidism, mixed hyperlipidemia, anxiety, depression, covid-19 (prior vaccination), allergy to amoxicillin/clavulanic acid (AUGMENTIN). The patient's concomitant medications in two weeks reported as yes. The patient had no other vaccine in four weeks. The patient experienced headache, muscle pain, fever, exhaustion, injection site swollen, red and itchy on 11Mar2021 at 11:00 AM. The patient did not have COVID tested post vaccination. No treatment for events. The outcome of events was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Headache; muscle pain; fever; exhaustion; injection site swollen, red and itchy; injection site swollen, red and itchy; injection site swollen, red and itchy; This is a spontaneous report from a contactable consumer (patient). A 48-year-old non-pregnant female patient received bnt162b2 (Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in left arm on 11Mar2021 08:15 AM (at the age of 48 years old) as single dose for covid-19 immunization. Medical history included asthma, high blood pressure, lymphedema, postoperative hypothyroidism, mixed hyperlipidemia, anxiety, depression, covid-19 (prior vaccination), allergy to amoxicillin/clavulanic acid (AUGMENTIN). The patient's concomitant medications in two weeks reported as yes. The patient had no other vaccine in four weeks. The patient experienced headache, muscle pain, fever, exhaustion, injection site swollen, red and itchy on 11Mar2021 at 11:00 AM. The patient did not have COVID tested post vaccination. No treatment for events. The outcome of events was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling cold, Pyrexia
Clinical narrative: feel cold; body was shaking and couldn't seem to warm up; fever; This is a spontaneous report from a contactable consumer (patient).  A 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot Number: EN6205) via an unspecified route of administration administered in left arm on 12Mar2021 at 08:00 (at 50 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. Medical history included "thalacimia (Mediterranean anemia)" as reported, from unspecified date. The patient had no known allergies. There were no concomitant medications. The patient previously took the first dose of BNT162B2 (Lot number: EN6205) via an unspecified route of administration administered in left arm on 19Feb2021 at 08:00 as single dose for COVID-19 immunization. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. About 38 hours after the vaccine, the patient started to feel cold. Eventually, the patient was so cold her body was shaking and couldn't seem to warm up. Probably 3 hours later a broke a fever. All were non-serious on 13Mar2021 at 22:30. No treatment received for the events. Outcome of the events was recovered on unspecified date in Mar2021.  No follow-up attempts are possible. No further information is expected.